Adenosine in tissue protection and tissue regeneration - PubMed (original) (raw)
Review
Adenosine in tissue protection and tissue regeneration
Joel Linden. Mol Pharmacol. 2005 May.
Abstract
Adenosine promotes tissue protection and repair through four general modes of action: increased oxygen supply/demand ratio, preconditioning, anti-inflammatory effects, and stimulation of angiogenesis. A novel means by which adenosine stimulates angiogenesis is the topic of the article by Desai et al. in the April 2005 issue of Molecular Pharmacology. The report demonstrates that agonists of A2A adenosine receptors inhibit the release of the anti-angiogenic factor thrombospondin 1. Multiple cell types and all four adenosine receptors participate in these responses. Exploiting these effects of adenosine has great therapeutic potential.
Comment on
- Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.
Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN. Desai A, et al. Mol Pharmacol. 2005 May;67(5):1406-13. doi: 10.1124/mol.104.007807. Epub 2005 Jan 26. Mol Pharmacol. 2005. PMID: 15673602
Similar articles
- Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
Stone TW, Ceruti S, Abbracchio MP. Stone TW, et al. Handb Exp Pharmacol. 2009;(193):535-87. doi: 10.1007/978-3-540-89615-9_17. Handb Exp Pharmacol. 2009. PMID: 19639293 Review. - Adenosine, an endogenous distress signal, modulates tissue damage and repair.
Fredholm BB. Fredholm BB. Cell Death Differ. 2007 Jul;14(7):1315-23. doi: 10.1038/sj.cdd.4402132. Epub 2007 Mar 30. Cell Death Differ. 2007. PMID: 17396131 Review. - Adenosine and renal tubular function.
Di Sole F. Di Sole F. Curr Opin Nephrol Hypertens. 2008 Jul;17(4):399-407. doi: 10.1097/MNH.0b013e32830321e1. Curr Opin Nephrol Hypertens. 2008. PMID: 18660677 Review. - Adenosine receptor targeting in health and disease.
Gessi S, Merighi S, Fazzi D, Stefanelli A, Varani K, Borea PA. Gessi S, et al. Expert Opin Investig Drugs. 2011 Dec;20(12):1591-609. doi: 10.1517/13543784.2011.627853. Epub 2011 Oct 22. Expert Opin Investig Drugs. 2011. PMID: 22017198 Review. - Influences of adenosine on the fetus and newborn.
Rivkees SA, Zhao Z, Porter G, Turner C. Rivkees SA, et al. Mol Genet Metab. 2001 Sep-Oct;74(1-2):160-71. doi: 10.1006/mgme.2001.3217. Mol Genet Metab. 2001. PMID: 11592813 Review.
Cited by
- The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases.
Eisenstein A, Patterson S, Ravid K. Eisenstein A, et al. J Cell Physiol. 2015 Dec;230(12):2891-7. doi: 10.1002/jcp.25043. J Cell Physiol. 2015. PMID: 25975415 Free PMC article. Review. - Adenosine receptors as therapeutic targets.
Jacobson KA, Gao ZG. Jacobson KA, et al. Nat Rev Drug Discov. 2006 Mar;5(3):247-64. doi: 10.1038/nrd1983. Nat Rev Drug Discov. 2006. PMID: 16518376 Free PMC article. Review. - The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.
Bagatini MD, Dos Santos AA, Cardoso AM, Mânica A, Reschke CR, Carvalho FB. Bagatini MD, et al. J Immunol Res. 2018 Aug 12;2018:4892473. doi: 10.1155/2018/4892473. eCollection 2018. J Immunol Res. 2018. PMID: 30159340 Free PMC article. Review. - Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rats.
Huang SQ, Tang CL, Sun SQ, Yang C, Xu J, Wang KJ, Lu WT, Huang J, Zhuo F, Qiu GP, Wu XY, Qi W. Huang SQ, et al. CNS Neurosci Ther. 2014 Jan;20(1):20-31. doi: 10.1111/cns.12155. Epub 2013 Aug 13. CNS Neurosci Ther. 2014. PMID: 23937638 Free PMC article. - Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock.
Feuerecker M, Sudhoff L, Crucian B, Pagel JI, Sams C, Strewe C, Guo A, Schelling G, Briegel J, Kaufmann I, Choukèr A. Feuerecker M, et al. Sci Rep. 2018 Jan 29;8(1):1754. doi: 10.1038/s41598-018-19976-w. Sci Rep. 2018. PMID: 29379043 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous